Peter Hecht
Vermögen: 3 Mio $ am 30.06.2026
Vermögen: 3 Mio $ am 30.06.2026
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc., founded in 1998, where the title held was Chief Executive Officer & Director from 1998 to 2019.
Dr. Hecht is the founder of Cyclerion Therapeutics, Inc., founded in 2019, holding the title of Director starting in 2023.
Current jobs include Chief Executive Officer & Director at Tisento Therapeutics, Inc. since 2023, Director at Kallyope, Inc. since 2020, and Director at Mythic Therapeutics, Inc. Former jobs include Director at Microbia, Inc. and Director at Whitehead Institute for Biomedical Research.
Education includes undergraduate and graduate degrees from Stanford University and a doctorate from the University of California, Berkeley.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYCLERION THERAPEUTICS,INC. 12,91 % | 30.03.2026 | 559 203 ( 12,91 % ) | 2 Mio $ | 30.06.2026 |
| 30.03.2026 | 351 037 ( 100 % ) | 1 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.04.2019 |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Direktor/Vorstandsmitglied | 20.02.2020 |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Direktor/Vorstandsmitglied | - |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Vorstandsvorsitzender | 01.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Gründer | 01.04.2019 |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Direktor/Vorstandsmitglied | - |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. BiotechnologyHealth Technology Engages in discovering and developing of novel, neurological and metabolic therapeutics | Health Technology |
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treat diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen